Pharmaceutical

FDA rejects Lykos MDMA therapy, asks for another Phase ...

The company plans to ask the US FDA to reconsider its request for an additional ...

FDA approves IASO Bio’s IND for equecabtagene autoleucel

IASO Biotherapeutics has secured the US Food and Drug Administration (FDA) appro...

Momentum Biotechnologies and Cube Biotech link for ther...

Momentum Biotechnologies has partnered with Cube Biotech for supporting clients ...

Recursion and Exscientia merge to form drug discovery c...

Recursion has signed an agreement to merge with Exscientia to create a global te...

MSD sets sights on bispecific antibody market with Curo...

For an upfront payment of $700m, MSD will gain access to the CD3 and CD19-target...

NICE supports Theramex’s Eladynos for post-menopause os...

Eladynos is a synthetic peptide analogue of parathyroid hormone-related protein ...

Eli Lilly boosts sales forecast by $3bn as diabetes and...

Days after competitor Novo Nordisk posted underwhelming Wegovy sales, Eli Lilly ...

AN2 slashes staff by 50% after lead antibiotic flunks i...

The company stock was down by over 22.7% in premarket trading as AN2 shared tria...

Adaptimmune leads in soft tissue sarcoma therapy with f...

TCR therapies are minimally engineered and can target both cell surface antigens...

Gilead Sciences reports net income rise in Q2 2024

Gilead Sciences has reported net income attributable to the company at $1.61bn, ...

WuXi Biologics and Medigene link on T cell engagers for...

Global contract research, development and manufacturing organisation (CRDMO) WuX...

How the GLP-1 receptor agonist market could hit $168bn ...

In the past few years, there has been a significant increase in the use of GLP-1...

Takeda’s ADZYNMA gains EU approval for cTTP treatment

The European Commission (EC) has approved Takeda's ADZYNMA (recombinant ADAMTS13...

Amneal’s CREXONT gains FDA approval for Parkinson’s tre...

The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals' C...

GSK’s Jemperli approved for advanced endometrial cancer...

GSK Singapore obtained the Singapore HSA approval for a new indication for Jempe...

US FDA approves Novartis’ Fabhalta in IgAN treatment

Novartis has secured US Food and Drug Administration (FDA) accelerated approval ...